These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7998122)

  • 21. Biological characteristics of a novel immunosuppressant, IR-1116, specific for B lymphocytes.
    Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):734-7. PubMed ID: 8382385
    [No Abstract]   [Full Text] [Related]  

  • 22. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis.
    Rogers AM; Thilenius AR; Russell JH
    J Immunol; 1997 Oct; 159(7):3140-7. PubMed ID: 9317111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 25. Computerized quantitation of immunosuppressive synergy for clinical protocol design.
    Chou TC; Stepkowski SM; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3043-5. PubMed ID: 7940955
    [No Abstract]   [Full Text] [Related]  

  • 26. Murine skin allograft histocompatibility combinations susceptible to induction of tolerance by intraportal inoculation of allogeneic spleen cells.
    Yabusaki N; Komatsu H; Tasaka K; Ueno A
    Transplant Proc; 1993 Apr; 25(2):2124-5. PubMed ID: 8470290
    [No Abstract]   [Full Text] [Related]  

  • 27. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 28. Anisomycin inhibits the behaviors of T cells and the allogeneic skin transplantation in mice.
    Xing F; Yu Z; Liu J; Di J; Zeng S; Chen D; Chen L; Fang Z; Guo Z; Pan S; Wang J; Li Y; Hao W; Fan Z; Teng Z; Chen G; Chen Z; Mao C; Long Y; Liu N
    J Immunother; 2008; 31(9):858-70. PubMed ID: 18833001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological studies with Norvaline2-cyclosporine (SDZ OG 37-325) in comparison with cyclosporine (Sandimmun): a summary.
    Hiestand PC; Traber R; Borel JF
    Transplant Proc; 1994 Oct; 26(5):2999-3001. PubMed ID: 7940947
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
    Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
    Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive effect of bactobolamine on in vitro lymphocyte alloactivation: synergism with cyclosporine.
    Imai T; Inoue S; Kuzuhara K; Hosoya Y; Honda M; Takasaki E; Yoshida KI; Manaka K; Nishimura Y; Bekku Y; Tomikawa S; Nagao T; Uchida H
    Transplant Proc; 2000 Nov; 32(7):2060-2. PubMed ID: 11120066
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC; Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract]   [Full Text] [Related]  

  • 33. [Method for isolation of the immunosuppressive peptide fraction in human blood].
    Lostický C; Cajthamlová H; Soucek J; Bednarík T
    Cesk Farm; 1981 Sep; 30(7):230-2. PubMed ID: 7030493
    [No Abstract]   [Full Text] [Related]  

  • 34. Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine.
    Thomson AW; Woo J; Lemster B; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):704-5. PubMed ID: 8438446
    [No Abstract]   [Full Text] [Related]  

  • 35. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
    Yaron I; Yaron R; Oluwole SF; Hardy MA
    Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo immunosuppression with lymphocyte chalone.
    Lilly JR; Houck JC
    Surg Forum; 1973; 24():339-40. PubMed ID: 4282524
    [No Abstract]   [Full Text] [Related]  

  • 37. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V
    Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the immunosuppressive effect of SMS 201-995 and its synergic action with FK 506.
    Perego C; Lattuada D; Casnici C; Gatti S; Orsenigo R; Panagiotis S; Franco P; Marelli O
    Transplant Proc; 1998 Aug; 30(5):2182-4. PubMed ID: 9723434
    [No Abstract]   [Full Text] [Related]  

  • 39. A role for effectors of cellular immunity in epimorphic regeneration of amphibian limbs.
    Fahmy GH; Sicard RE
    In Vivo; 2002; 16(3):179-84. PubMed ID: 12182113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive effects of emodin: an in vivo and in vitro study.
    Liu YX; Shen NY; Liu C; Lv Y
    Transplant Proc; 2009 Jun; 41(5):1837-9. PubMed ID: 19545739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.